KLP Kapitalforvaltning
TYRA icon

KLP Kapitalforvaltning’s Tyra Biosciences TYRA Stock Holding History

KLP Kapitalforvaltning’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$112K Hold
5,100
– – ﹤0.01% 2044
2026
Q2 		$163K Buy
5,100
+2,200
+76% +$72.8K ﹤0.01% 1967
2026
Q1 		$111K Buy
+2,900
New +$93.9K ﹤0.01% 2027
2025
Q2 		– Sell
-2,200
Closed -$20.5K – 2262
2025
Q1 		$20.5K Hold
2,200
– – ﹤0.01% 2244
2024
Q4 		$30.6K Buy
+2,200
New +$39.9K ﹤0.01% 2276

Other funds holding TYRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Canaan Partners XI
Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

KLP Kapitalforvaltning's TYRA Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Tyra Biosciences (TYRA) position steady in Q3 2026 at 5,100 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

KLP Kapitalforvaltning first reported a position in TYRA in Q4 2024 and has held it in 5 quarters since. The position peaked at $163K in Q2 2026. 99 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • KLP Kapitalforvaltning held 5,100 shares of Tyra Biosciences worth $112K as of Q3 2026.
  • KLP Kapitalforvaltning left its Tyra Biosciences share count unchanged in Q3 2026.
  • Tyra Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #2044 holding.
  • KLP Kapitalforvaltning first reported a position in Tyra Biosciences in Q4 2024 and has held it in 5 quarters since.
  • KLP Kapitalforvaltning's Tyra Biosciences position peaked at $163K in Q2 2026.
  • 99 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.